Upregulation of Endothelin-1/Endothelin A Receptor Expression Correlates with Heparanase Expression in Ovarian Carcinoma

Background: Heparanase and endothelin-1/endothelin A receptor (ET-1/ETAR) expressions increase in cancer. This condition enhances tumor progression and correlates with poor survival. Limited data are documented regarding the role of heparanase and ET-1/ETAR in epithelial ovarian cancer (EOC). We sou...

Full description

Bibliographic Details
Main Authors: Nungki Anggorowati, Ahmad Ghozali, Irianiwati Widodo, Dwi Cahyani Ratna Sari, Muhammad Mansyur Romi, Nur Arfian
Format: Article
Language:English
Published: Shiraz University of Medical Sciences 2018-05-01
Series:Iranian Journal of Medical Sciences
Subjects:
Online Access:http://ijms.sums.ac.ir/index.php/IJMS/article/view/3440
_version_ 1811286192636821504
author Nungki Anggorowati
Ahmad Ghozali
Irianiwati Widodo
Dwi Cahyani Ratna Sari
Muhammad Mansyur Romi
Nur Arfian
author_facet Nungki Anggorowati
Ahmad Ghozali
Irianiwati Widodo
Dwi Cahyani Ratna Sari
Muhammad Mansyur Romi
Nur Arfian
author_sort Nungki Anggorowati
collection DOAJ
description Background: Heparanase and endothelin-1/endothelin A receptor (ET-1/ETAR) expressions increase in cancer. This condition enhances tumor progression and correlates with poor survival. Limited data are documented regarding the role of heparanase and ET-1/ETAR in epithelial ovarian cancer (EOC). We sought to characterize the correlation between heparanase and ET-1/ETAR in EOC. Methods: Thirty patients with benign and malignant ovarian neoplasms were recruited in this study. Neoplasm subtypes were diagnosed by pathologists. RNA extraction was done in fresh frozen neoplasms while immunohistochemical (IHC) staining was done on ETAR, heparanase, and proliferation (Ki-67 antigen) in paraffin sections. Reverse transcriptase PCR was done to quantify the expression of preproET-1 (ppET-1), ETAR, and heparanase. ETAR and heparanase histoscores were done based on IHC staining. The Independent Samples t Test, ANOVA, and correlations were used for statistical analysis. Results: Heparanase and ETAR histoscores, ppET-1 and ETAR mRNA levels, and Ki-67 were significantly higher in the group with EOC than in the benign or borderline group, regardless of the histopathological types. The heparanase histoscore correlated with the ETAR histoscore (r=0.484, P=0.007) and the ETAR mRNA level (r=0.551, P=0.003). The level of ppET-1 mRNA correlated with both ETAR mRNA level and ETAR histoscore (r=0.603, P=0.001 and r=0.455, P=028, respectively). The ovarian neoplasms with high ppET-1 mRNA levels also tended to have high heparanase mRNA levels; however, the correlation was weak (r=0.354, P=0.07). Ki-67 correlated with the heparanase and ETAR histoscores (r=0.381, P=0.038 and r=0.477, P=0.008, respectively). Conclusion: Heparanase and ETAR were upregulated in EOC, and the correlation between heparanase and ETAR expressions was also elucidated in the current study.
first_indexed 2024-04-13T02:56:08Z
format Article
id doaj.art-943b05a4305e4b699c75344bc1a6520f
institution Directory Open Access Journal
issn 0253-0716
1735-3688
language English
last_indexed 2024-04-13T02:56:08Z
publishDate 2018-05-01
publisher Shiraz University of Medical Sciences
record_format Article
series Iranian Journal of Medical Sciences
spelling doaj.art-943b05a4305e4b699c75344bc1a6520f2022-12-22T03:05:38ZengShiraz University of Medical SciencesIranian Journal of Medical Sciences0253-07161735-36882018-05-01433286295Upregulation of Endothelin-1/Endothelin A Receptor Expression Correlates with Heparanase Expression in Ovarian CarcinomaNungki Anggorowati0Ahmad Ghozali1Irianiwati Widodo2Dwi Cahyani Ratna Sari3Muhammad Mansyur Romi4Nur Arfian5Department of Anatomical Pathology, Universitas Gadjah Mada/Sardjito Hospital, Yogyakarta, IndonesiaDepartment of Anatomical Pathology, Universitas Gadjah Mada/Sardjito Hospital, Yogyakarta, IndonesiaDepartment of Anatomical Pathology, Universitas Gadjah Mada/Sardjito Hospital, Yogyakarta, IndonesiaDepartment of Anatomy, Universitas Gadjah Mada/Sardjito Hospital, Yoyakarta, IndonesiaDepartment of Anatomy, Universitas Gadjah Mada/Sardjito Hospital, Yoyakarta, IndonesiaDepartment of Anatomy, Universitas Gadjah Mada/Sardjito Hospital, Yoyakarta, IndonesiaBackground: Heparanase and endothelin-1/endothelin A receptor (ET-1/ETAR) expressions increase in cancer. This condition enhances tumor progression and correlates with poor survival. Limited data are documented regarding the role of heparanase and ET-1/ETAR in epithelial ovarian cancer (EOC). We sought to characterize the correlation between heparanase and ET-1/ETAR in EOC. Methods: Thirty patients with benign and malignant ovarian neoplasms were recruited in this study. Neoplasm subtypes were diagnosed by pathologists. RNA extraction was done in fresh frozen neoplasms while immunohistochemical (IHC) staining was done on ETAR, heparanase, and proliferation (Ki-67 antigen) in paraffin sections. Reverse transcriptase PCR was done to quantify the expression of preproET-1 (ppET-1), ETAR, and heparanase. ETAR and heparanase histoscores were done based on IHC staining. The Independent Samples t Test, ANOVA, and correlations were used for statistical analysis. Results: Heparanase and ETAR histoscores, ppET-1 and ETAR mRNA levels, and Ki-67 were significantly higher in the group with EOC than in the benign or borderline group, regardless of the histopathological types. The heparanase histoscore correlated with the ETAR histoscore (r=0.484, P=0.007) and the ETAR mRNA level (r=0.551, P=0.003). The level of ppET-1 mRNA correlated with both ETAR mRNA level and ETAR histoscore (r=0.603, P=0.001 and r=0.455, P=028, respectively). The ovarian neoplasms with high ppET-1 mRNA levels also tended to have high heparanase mRNA levels; however, the correlation was weak (r=0.354, P=0.07). Ki-67 correlated with the heparanase and ETAR histoscores (r=0.381, P=0.038 and r=0.477, P=0.008, respectively). Conclusion: Heparanase and ETAR were upregulated in EOC, and the correlation between heparanase and ETAR expressions was also elucidated in the current study.http://ijms.sums.ac.ir/index.php/IJMS/article/view/3440Ovarian neoplasmsEndothelin-1ReceptorEndothelin AHeparanaseKi-67 antigen
spellingShingle Nungki Anggorowati
Ahmad Ghozali
Irianiwati Widodo
Dwi Cahyani Ratna Sari
Muhammad Mansyur Romi
Nur Arfian
Upregulation of Endothelin-1/Endothelin A Receptor Expression Correlates with Heparanase Expression in Ovarian Carcinoma
Iranian Journal of Medical Sciences
Ovarian neoplasms
Endothelin-1
Receptor
Endothelin A
Heparanase
Ki-67 antigen
title Upregulation of Endothelin-1/Endothelin A Receptor Expression Correlates with Heparanase Expression in Ovarian Carcinoma
title_full Upregulation of Endothelin-1/Endothelin A Receptor Expression Correlates with Heparanase Expression in Ovarian Carcinoma
title_fullStr Upregulation of Endothelin-1/Endothelin A Receptor Expression Correlates with Heparanase Expression in Ovarian Carcinoma
title_full_unstemmed Upregulation of Endothelin-1/Endothelin A Receptor Expression Correlates with Heparanase Expression in Ovarian Carcinoma
title_short Upregulation of Endothelin-1/Endothelin A Receptor Expression Correlates with Heparanase Expression in Ovarian Carcinoma
title_sort upregulation of endothelin 1 endothelin a receptor expression correlates with heparanase expression in ovarian carcinoma
topic Ovarian neoplasms
Endothelin-1
Receptor
Endothelin A
Heparanase
Ki-67 antigen
url http://ijms.sums.ac.ir/index.php/IJMS/article/view/3440
work_keys_str_mv AT nungkianggorowati upregulationofendothelin1endothelinareceptorexpressioncorrelateswithheparanaseexpressioninovariancarcinoma
AT ahmadghozali upregulationofendothelin1endothelinareceptorexpressioncorrelateswithheparanaseexpressioninovariancarcinoma
AT irianiwatiwidodo upregulationofendothelin1endothelinareceptorexpressioncorrelateswithheparanaseexpressioninovariancarcinoma
AT dwicahyaniratnasari upregulationofendothelin1endothelinareceptorexpressioncorrelateswithheparanaseexpressioninovariancarcinoma
AT muhammadmansyurromi upregulationofendothelin1endothelinareceptorexpressioncorrelateswithheparanaseexpressioninovariancarcinoma
AT nurarfian upregulationofendothelin1endothelinareceptorexpressioncorrelateswithheparanaseexpressioninovariancarcinoma